Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter studyTatsuya Ide, Takuji Torimura, Hiroshi Yatsuhashi et al.|Hepatology International|2019Cited by 56
Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort studyMasahito Nakano, Takuji Torimura, Hironori Koga et al.|Cancer Medicine|2019Cited by 38